Health & Food
Qsymia weight-loss drug approved by FDA
WASHINGTON (KABC) -- A new prescription drug to fight obesity has been approved by the Food and Drug Administration.
The pill, called Qsymia, is designed for those who are overweight and have at least one weight-related condition, such as high blood pressure or diabetes. It is expected to help them lose 10 percent of their weight, in combination with diet and exercise.
The drug was previously known as Qnexa. The FDA rejected it two years ago because of fears over increased heart rate and birth defects.
It was approved after the manufacturer began a risk management program, controlling its use.
Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, which have been known to help with weight loss. Phentermine is indicated for short-term weight loss in overweight or obese adults who are exercising and eating a reduced-calorie diet. Topiramate is an anticonvulsant that makes people feel more satisfied after eating.
The drug's maker, Vivus Inc., said it plans to bring the drug to market in the fourth quarter of this year. It hasn't yet decided what the pills will cost.
The Associated Press contributed to this report.
health, health care, obesity, fda, health & food
- Delivery man fatally shot in South Los Angeles
- Westlake High coach accused of sex with teen
- Yucaipa High teacher accused of sex with teen 41 min ago
- 2 boys molested at different South Bay parks
- Del Taco customers charged thousands for meal
- Man's body found in vehicle in San Bernardino 27 min ago
- LA Times building threat: Man detained by LAPD
- FBI seeks '76 murder suspect, possibly in SoCal
- Earthquake strikes off Papua New Guinea
- abcnews: Eclectic early summer festivals
- SKorean sunken ferry captain, 2 crew arrested
- 13th body pulled following Everest avalanche
- Rooney to be buried at Hollywood Forever 1 min ago
- OTRC: Miley Cyrus postpones whole tour